Evaluation of mifepristone as a once a month contraceptive pill.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 19026402.
- Also identified by DOI 10.1016/j.ajog.2008.09.005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this study was to assess the efficacy and safety of mifepristone as a contraceptive pill. A prospective case-control study was conducted in a tertiary care center of North India. The study group (n = 86) was given 200-mg mifepristone tablets on the 16th day of the menstrual cycle. The control group (n = 92) received combined oral contraceptive (COC) as per protocol. Subjects were followed for drug compliance, satisfaction, side effects, and failure. Acceptability of mifepristone was significantly higher in educated population (P < .001), with fewer side effects (P = .001), good satisfaction (P < .001), and higher compliance rate (P = .05). The oral contraceptive pill group had higher adverse biochemical parameters. Mifepristone can be used as a monthly contraceptive pill effectively.
Medical subject headings
- Contraception
- Contraceptives, Oral, Synthetic
- Mifepristone
- Patient Satisfaction